SUMO1P3 and breast carcinoma: Since SUMO1P3 has been demonstrated to bind to miR-320a in breast cancer (11) and hepatocellular carcinoma (21) facilitating tumor progression, we investigated the presence of miR-320a in the urine of bladder cancer patients and controls.